Page 22 - CASA Bulletin of Anesthiology 2021, Vol 8, No. 6 (1)

CASA Bulletin of Anesthesiology

Covid-19 pain? We need to develop new drugs targeted and specified for treatment of Covid-19
pain. What is the mechanism of Covid-19 pain? Why pain is becoming part of sequelae in Long
COVID for some patients?

References

1. WHO. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/ (accessed Nov, 25, 2021)
2. Widyadharma IP E, Sari N N S P , Pradnyaswari K E , Yuwana K T , Adikarya IP G D, Tertia C, Wijayanti I A
S, Indrayani I A S and Utami D K I. Pain as clinical manifestations of COVID-19 infection and its management
in the pandemic era: a literature review. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
(2020) 56:121 https://doi.org/10.1186/s41983-020-00258-0
3. Weng L M, Su X, Wang X Q.. Pain Symptoms in Patients with Coronavirus Disease (COVID-19): A Literature
Review. Journal of Pain Research 2021:14 147–159
4. Chow EJ, Schwartz NG, Tobolowsky FA, et al. Symptom screening at illness onset of health care personnel
with SARS-CoV-2 infection in King County, Washington. JAMA. 2020;323:2087.
doi:10.1001/jama.2020.6637)
5. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan,
China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
6. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med.
2020;382:1708–172
7. Ramani SL, Samet J, Franz CK, Hsieh C, & Nguyen CV, Horbinski C, Deshmukh S. Musculoskeletal
involvement of COVID-19: review of imaging. Skeletal Radiology. 18 February 2021
8. Revzin MV, Raza S, Warshawsky R, et al. Multisystem imaging manifestations of COVID-19. Part 1. Viral
pathogenesis and pulmonary and vascular system complications. Radiographics. 2020;40(6):1574–99.
9. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and
treatment of corona virus disease 2019 (COVID-19): a review. JAMA. 2020;324(8): 782–93
10. Paliwal VK, Garg RK, Gupta A, Tejan N. Neuromuscular presentations in patients with COVID-19. Neurol Sci.
2020;41(11):3039– 56.
11. Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. SARS-CoV-2 and nervous
system: from pathogenesis to clinical manifestation. J Neuroimmunol. 2020;350:577436
12. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel
coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395 (10223):507–513.
doi:10.1016/S0140-6736(20)30211-7
13. National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects
of COVID-19 NICE guideline; c2020. https://www.nice.org.uk/guidance/ng188
14. Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-
2 infection: illness beyond acute infection and public health implications. JAMA 2020;324:2251-2.
doi:10.1001/jama.2020.22717
15. Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a
cohort study. Lancet 2021;397:220-32. doi:10.1016/S0140-6736(20)32656-8
16. Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients
hospitalized with COVID-19. Ann Intern Med 2021;174:576-8. doi:10.7326/M20-5661
17. Carfì A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group. Gemelli against C-P-
ACSG. Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603-5. doi:10.1001/
jama.2020.12603
18. Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of
symptoms and their impact. MedRxiv 2020;12.24.20248802
19. Raman B, Cassar MP, Tunnicliffe EM, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital
organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge.
EClinicalMedicine 2021;31:100683. doi:10.1016/j. eclinm.2020.100683
20. Sollini M, Ciccarelli M, Cecconi M, et al. Vasculitis changes in COVID-19 survivors with persistent symptoms:
an [18F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging 2021;48:1460-6. doi:10.1007/ s00259-020-05084-3
21. Dennis A, Wamil M, Kapur S, et al. Multi-organ impairment in low-risk individuals with long COVID.
MedRxiv 2020;10.14.20212555 [preprint] doi:10.1101/2020.10.14.20212555
P a g e 21 | 69